ESC preview – Medicines Company hopes for a starring role
Novartis has been reduced to a Paragon data dredge, but results with The Medicines Company’s inclisiran, Astrazeneca’s Brilinta and Cellaegis’ AutoRIC device should pique…
Ablation groups scramble to cope with Cabana
The Cabana trial has finally reported, but the data are inconclusive.
